Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Related Posts
2025 Trends: Investing in Clinical Data
In a recent video interview with Applied Clinical Trials, Dipanwita Das, CEO & co-founder at Sorcero, discussed advancements and future…
Long-Term KATHERINE Trial Analysis Shows Kadcyla Significantly Improves Survival in HER2-Positive Early Breast Cancer
Credit: LASZLO | stock.adobe.com An updated prespecified final analysis of the Phase III KATHERINE trial (NCT01772472) found that adjuvant treatment…
Lomecel-B Meets Key Objectives in Phase IIa Alzheimer’s Study
Image Credit: © LIGHTFIELD STUDIOS – stock.adobe.com Lomecel-B, a living cell product for the treatment of Alzheimer’s Disease, has met…
